Stein Jeffrey's Form 4 filing
Cidara Therapeutics, Inc. (CDTX) · filed Jan 7, 2026
- Accession no.
- 0001478831-26-000004
- Filed
- Jan 7, 2026
- Trade date
- May 23, 2016-Dec 31, 2021
- Filing delay
- 3,516 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions. Open-market purchases total $339.1K. It was filed 3516 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stein JeffreyCIK 0001478831 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2016 | Common Stock | JOtherDisposed | −270 | –F1 | – | 10,025 | Direct | |
| Mar 31, 2017 | Common Stock | JOtherDisposed | −645 | $155.00F2 | −$99,975 | 9,380 | Direct | |
| Mar 31, 2017 | Common Stock | PPurchaseAcquired | +645 | $155.00F2 | +$99,975 | 65,754 | Indirect | |
| Jun 5, 2017 | Common Stock | JOtherDisposed | −750 | $118.95F2 | −$89,212.5 | 8,630 | Direct | |
| Jun 5, 2017 | Common Stock | PPurchaseAcquired | +750 | $118.95F2 | +$89,212.5 | 66,504 | Indirect | |
| Sep 12, 2017 | Common Stock | JOtherDisposed | −367 | $135.80F2 | −$49,838.6 | 8,263 | Direct | |
| Sep 12, 2017 | Common Stock | PPurchaseAcquired | +367 | $135.80F2 | +$49,838.6 | 66,871 | Indirect | |
| Nov 10, 2020 | Common Stock | JOtherDisposed | −2,500 | $40.01F2 | −$100,025 | 5,763 | Direct | |
| Nov 10, 2020 | Common Stock | PPurchaseAcquired | +2,500 | $40.01F2 | +$100,025 | 69,371 | Indirect | |
| Dec 10, 2020 | Common Stock | JOtherDisposed | −658 | $0.00 | $0 | 1,442 | Indirect | |
| Dec 31, 2021 | Common Stock | GGiftDisposed | −1,873 | $0.00 | $0 | 67,498 | Indirect | |
| Dec 31, 2021 | Common Stock | GGiftAcquired | +937 | $0.00 | $0 | 2,379 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Form 4 originally filed on May 23, 2016 erroneously overstated the Amount of Securities Beneficially Owned by Reporting Person.
Referenced by the price of 1 transaction in Table I.
- F2
The number of securities and price reported herein have been adjusted to reflect the 1-for-20 reverse stock split effected by the Issuer on April 24, 2024.
Referenced by the price of 8 transactions in Table I.